Wednesday, December 20, 2023 The Canadian Cancer Trials Group would like to acknowledge and send a warm thank you to Richard Wassersug for his commitment and dedication as a CCTG Patient Representative, he will be leaving the committee at the end of 2023. Richard has been a CCTG patient representative since April 2015 and has been a member of the Genitourinary Disease Site Committee since that time. Richard was diagnosed with prostate cancer over 20 years ago and has had surgery, radiation, and hormone therapy to control his disease. As a scientist, he found the side effects of the drugs so interesting that he began studying them. This has led to a variety of academic papers on the impact of cancer treatments on the quality of life of patients as well as personal essays on survivorship, advocacy, and patient engagement in cancer research. We hope you will join us in extending our gratitude to Richard for his participation and invaluable contributions over the last 8 + years.
